ShangBay Capital is a venture capital company that brings investors access to best-in-class investments in the U.S. medical devices technology, biotechnology, and healthcare technology sectors through early-stage venture equity participation. We have a strong leadership team with deep ties to strategics, innovators, and enjoy partnering with experienced founders on disruptive technologies.
ShangBay Capital has established relationships with best-in-class investors, entrepreneurs, KOLs, strategics, and innovators of the industry. Our investments cover founders who have built disruptive companies that address high unmet clinical needs at reduced costs.
With a combined 100+ years of experience in various specialties, we cover fields spanning across medical devices, biotechnology, biopharmaceuticals, artificial intelligence, and more. We seek to leverage our expertise and help founders satisfy large market needs and generate favorable returns.